Three global fashion giants are suing a Sydney-based boutique for allegedly importing and selling knockoff versions of their clothing.
A judge has shot down a bid by Cash Converters to recuse himself from hearing arguments for a $16.4 million class action settlement, saying his advice while still a barrister to the law firm running the proceedings did not give rise to apprehended bias.
The Australian Writers’ Guild has resolved its long-running dispute with the Audio-Visual Copyright Society alleging the royalties distributor misdirected millions in royalties owed to Australian screenwriters.
National car repair franchise Ultra Tune has been ordered to pay a $2.6 million penalty, with a judge finding the firm had not only breached the Franchising Code and the Australian Consumer Law by misleading a prospective franchisee but also misled the court in its defence of the case brought by the consumer watchdog.
An ecological landscaper suing the Retail Employees Superannuation Trust fund for an undeveloped climate change policy has lost an application for a maximum costs order in the public-interest case.
A Queensland law firm says litigation launched by a former client alleging she and other clients were charged excessive fees should not be run as a class action.
A senior member of the Fair Work Commission acted inappropriately when he shared a Twitter post critical of Labor leader Bill Shorten and the CFMMEU, but it did not mean he could be viewed as biased against the union, a full bench of the workplace tribunal has found.
A judge that dismissed an investor class action against the Public Trustee of Queensland over the failure of investment firm Octaviar Group improperly intervened in the cross-examination of one of the class’ witnesses, one of the judges that will hear an appeal of the dismissal was told.
Actor Craig McLachlan has won a bid to stay his defamation case against actress Christie Whelan Browne, Fairfax Media and the ABC in light of recent indecent assault charges brought against him, with a judge finding the cases deal with identical subject matter.
The Full Federal Court has expedited an appeal filed Christmas Eve by Sanofi-Aventis of a ruling that denied its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme.